HANLY ANN M. has filed 9 insider transactions across 1 company since February 2023.
Most recent transaction: a sale of 14168 shares of Vir Biotechnology, Inc. ($VIR) on February 24, 2025.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2025 | Vir Biotechnology, Inc. | $VIR | HANLY ANN M. | EVP & Chief Technology Officer | S | Common Stock | 14168 | $9.45 | 117,901.0000 | 137,143,286 | 10.73% | 0.01% |
| April 1, 2024 | Vir Biotechnology, Inc. | $VIR | HANLY ANN M. | EVP & Chief Technology Officer | S | Common Stock | 2711 | $10.05 | 132,080.5200 | 0 | 2.01% | 0.00% |
| Feb. 22, 2024 | Vir Biotechnology, Inc. | $VIR | HANLY ANN M. | EVP & Chief Technology Officer | A | Common Stock | 32500 | $0.00 | 147,087.5200 | 0 | 28.36% | 0.00% |
| Feb. 22, 2024 | Vir Biotechnology, Inc. | $VIR | HANLY ANN M. | EVP & Chief Technology Officer | S | Common Stock | 12296 | $10.05 | 134,791.5200 | 0 | 8.36% | 0.00% |
| Feb. 22, 2024 | Vir Biotechnology, Inc. | $VIR | HANLY ANN M. | EVP & Chief Technology Officer | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| March 30, 2023 | Vir Biotechnology, Inc. | $VIR | HANLY ANN M. | Chief Technology Officer | S | Common Stock | 2627 | $22.77 | 114,587.5200 | 0 | 2.24% | 0.00% |
| Feb. 22, 2023 | Vir Biotechnology, Inc. | $VIR | HANLY ANN M. | Chief Technology Officer | A | Common Stock | 37500 | $0.00 | 119,516.5200 | 0 | 45.72% | 0.00% |
| Feb. 23, 2023 | Vir Biotechnology, Inc. | $VIR | HANLY ANN M. | Chief Technology Officer | S | Common Stock | 2302 | $25.97 | 117,214.5200 | 0 | 1.93% | 0.00% |
| Feb. 22, 2023 | Vir Biotechnology, Inc. | $VIR | HANLY ANN M. | Chief Technology Officer | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |